Authors:
Corvazier, L
Messe, L
Salou, CLO
Young, RN
Fairclough, JPA
Ryan, AJ
Citation: L. Corvazier et al., Lamellar phases and microemulsions in model ternary blends containing amphiphilic block copolymers, J MAT CHEM, 11(11), 2001, pp. 2864-2874
Authors:
Fernyhough, CM
Young, RN
Poche, D
Degroot, AW
Bosscher, F
Citation: Cm. Fernyhough et al., Synthesis and characterization of polybutadiene and poly(ethylene-1-butene) combs, MACROMOLEC, 34(20), 2001, pp. 7034-7041
Authors:
Riendeau, D
Percival, MD
Brideau, C
Charleson, S
Dube, D
Ethier, D
Falgueyret, JP
Friesen, RW
Gordon, R
Greig, G
Guay, J
Mancini, J
Ouellet, M
Wong, E
Xu, L
Boyce, S
Visco, D
Girard, Y
Prasit, P
Zamboni, R
Rodger, IW
Gresser, M
Ford-Hutchinson, AW
Young, RN
Chan, CC
Citation: D. Riendeau et al., Etoricoxib (MK-0663): Preclinical profile and comparison with other agentsthat selectively inhibit cyclooxygenase-2, J PHARM EXP, 296(2), 2001, pp. 558-566
Citation: Cm. Fernyhough et Rn. Young, The synthesis of diene - Alkyl methacrylate diblock and heteroarm star copolymers, MACRO SYMP, 161, 2000, pp. 103-111
Authors:
Nicoll-Griffith, DA
Yergey, JA
Trimble, LA
Silva, JM
Li, C
Chauret, N
Gauthier, JY
Grimm, E
Leger, S
Roy, P
Therien, M
Wang, ZY
Prasit, P
Zamboni, R
Young, RN
Brideau, C
Chan, CC
Mancini, J
Riendeau, D
Citation: Da. Nicoll-griffith et al., Synthesis, characterization, and activity of metabolites derived from the cyclooxygenase-2 inhibitor rofecoxib (MK-0966, Vioxx (TM)), BIOORG MED, 10(23), 2000, pp. 2683-2686
Citation: Dma. Buzza et al., Linear melt rheology and small-angle X-ray scattering of AB diblocks vs A(2)B(2) four arm star block copolymers, MACROMOLEC, 33(22), 2000, pp. 8399-8414
Citation: B. Brocklehurst et Rn. Young, Rotation of aromatic hydrocarbons in viscous alkanes. 1. Methylcyclohexane, J PHYS CH A, 103(20), 1999, pp. 3809-3817
Citation: B. Brocklehurst et Rn. Young, Rotation of aromatic hydrocarbons in viscous alkanes. 2. Hindered rotationin squalane, J PHYS CH A, 103(20), 1999, pp. 3818-3824
Authors:
Gil, L
Han, YX
Opas, EE
Rodan, GA
Ruel, R
Seedor, JG
Tyler, PC
Young, RN
Citation: L. Gil et al., Prostaglandin E-2-bisphosphonate conjugates: Potential agents for treatment of osteoporosis, BIO MED CH, 7(5), 1999, pp. 901-919
Authors:
Prasit, P
Wang, Z
Brideau, C
Chan, CC
Charleson, S
Cromlish, W
Ethier, D
Evans, JF
Ford-Hutchinson, AW
Gauthier, JY
Gordon, R
Guay, J
Gresser, M
Kargman, S
Kennedy, B
Leblanc, Y
Leger, S
Mancini, J
O'Neill, GP
Ouellet, M
Percival, MD
Perrier, H
Riendeau, D
Rodger, I
Tagari, P
Therien, M
Vickers, P
Wong, E
Xu, LJ
Young, RN
Zamboni, R
Boyce, S
Rupniak, N
Forrest, N
Visco, D
Patrick, D
Citation: P. Prasit et al., The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor, BIOORG MED, 9(13), 1999, pp. 1773-1778
Authors:
Han, YX
Giroux, A
Lepine, C
Laliberte, F
Huang, Z
Perrier, H
Bayly, CI
Young, RN
Citation: Yx. Han et al., Solid phase parallel synthesis of highly substituted thiophene derivativesand identification of novel phosphodiesterase-4 (PDE-4) inhibitors, TETRAHEDRON, 55(39), 1999, pp. 11669-11685
Citation: Dma. Buzza et al., Anomalous difference in the order-disorder transition temperature comparing a symmetric diblock copolymer AB with its hetero-four-arm star analog A(2)B(2), MACROMOLEC, 32(22), 1999, pp. 7483-7495
Authors:
McLeish, TCB
Allgaier, J
Bick, DK
Bishko, G
Biswas, P
Blackwell, R
Blottiere, B
Clarke, N
Gibbs, B
Groves, DJ
Hakiki, A
Heenan, RK
Johnson, JM
Kant, R
Read, DJ
Young, RN
Citation: Tcb. Mcleish et al., Dynamics of entangled H-polymers: Theory, rheology, and neutron-scattering, MACROMOLEC, 32(20), 1999, pp. 6734-6758
Citation: Cm. Fernyhough et al., Synthesis and characterization of polyisoprene-poly(methyl methacrylate) AB diblock and A(2)B(2) heteroarm star copolymers, MACROMOLEC, 32(18), 1999, pp. 5760-5764
Authors:
Chan, CC
Boyce, S
Brideau, C
Charleson, S
Cromlish, W
Ethier, D
Evans, J
Ford-Hutchinson, AW
Forrest, MJ
Gauthier, JY
Gordon, R
Gresser, M
Guay, J
Kargman, S
Kennedy, B
Leblanc, Y
Leger, S
Mancini, J
O'Neill, GP
Ouellet, M
Patrick, D
Percival, MD
Perrier, H
Prasit, P
Rodger, I
Tagari, P
Therien, M
Vickers, P
Visco, D
Wang, Z
Webb, J
Wong, E
Xu, LJ
Young, RN
Zamboni, R
Riendeau, D
Citation: Cc. Chan et al., Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, J PHARM EXP, 290(2), 1999, pp. 551-560